Independent origin of multiple foci of prostatic intraepithelial neoplasia: comparison with matched foci of prostate carcinoma.
about
NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinomaDifferences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donorsMolecular genetic evidence for different clonal origins of epithelial and stromal components of phyllodes tumor of the prostate.The clonal origin and clonal evolution of epithelial tumours.PTOV1, a novel protein overexpressed in prostate cancer containing a new class of protein homology blocks.Targeted high throughput sequencing in clinical cancer settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneityMolecular genetics of prostate cancer: new prospects for old challengesThe pathogenesis of prostate cancer: from molecular to metabolic alterations.High-grade prostatic intraepithelial neoplasia.Prostatic intraepithelial neoplasia and putative precursor lesions of prostate cancer: a clinical perspective.Emerging targets in the AKT pathway for treatment of androgen-independent prostatic adenocarcinoma.Staging of prostate cancer.Contemporary clinical management of isolated high-grade prostatic intraepithelial neoplasia.Prostatic stem cells.Evidence for field cancerization of the prostate.G proteins in cancer: the prostate cancer paradigm.Coexistence of benign phyllodes tumor and invasive ductal carcinoma in distinct breasts: case report.Innovative strategies for image-guided proton treatment of prostate cancer.Links between Propionibacterium acnes and prostate cancer.Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization.Precursor lesions of prostate cancer.Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signalingOrgan-wide telomeric status in diseased and disease-free prostatic tissues.Androgen regulation of prostate cancer: where are we now?Understanding the pathological features of focality, grade and tumour volume of early-stage prostate cancer as a foundation for parenchyma-sparing prostate cancer therapies: active surveillance and focal targeted therapy.Precursors of prostate cancer.The complexity of prostate cancer: genomic alterations and heterogeneity.Clinical variability and molecular heterogeneity in prostate cancer.HES5 silencing is an early and recurrent change in prostate tumourigenesis.Next generation patient-derived prostate cancer xenograft models.Can prostate biopsies predict suitability for nerve-sparing radical prostatectomy?Broadening of transgenic adenocarcinoma of the mouse prostate (TRAMP) model to represent late stage androgen depletion independent cancer.Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications.Telomere attrition in isolated high-grade prostatic intraepithelial neoplasia and surrounding stroma is predictive of prostate cancer.Nkx3.1 controls the DNA repair response in the mouse prostate.High-resolution genome-wide copy-number analysis suggests a monoclonal origin of multifocal prostate cancer.Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma.PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade.Concordance Between Prostate Needle Biopsy and Surgical Histopathology in a Primarily African-American Population.Complex patterns of ETS gene alteration arise during cancer development in the human prostate.
P2860
Q21563424-754ADCB1-DECF-47E4-9F2C-5D2C34821222Q24815497-DD3B9438-6035-4B9F-BDB6-ECEC64050F87Q33207642-85E61C4E-8699-439C-A7D7-D627400F9EE2Q33890376-731E5723-5943-43B6-A0DD-14F9395DE9C0Q33943431-904EC8D3-39BB-4B58-A9EB-53B4E2E95755Q34035161-17580455-9292-4338-BC52-EACE2724E5DCQ34127462-DF08AD96-6F98-4C0B-B8FB-C21B7C8C3503Q34201846-6E54C74D-F863-4CB6-B177-2D2B3F14667EQ34291962-32CB85C2-416D-4DE0-A1B6-EA0C385FE0C9Q34304458-6DCFCDCD-60B4-4756-9AEF-96ED67A5B72CQ34568941-B143C5EC-2217-4EC9-8A04-FAFBE058094DQ34634756-14FBAECA-D98B-4C2E-9ED5-98F2221A2440Q34696497-21A07CFF-E0DD-4E2A-90C8-2C550B84519DQ34736918-649F5FC5-E41E-43C1-BC00-F8672A34CFCFQ34982560-0B244108-B843-432B-8FB7-C4667A862B1EQ35634255-46232F27-D9F0-44B1-B14A-0D2BF6C66BD9Q36167858-3A59CD4E-EE46-4657-9BB0-6D7E2838AC8CQ36427226-6A1ACB97-F45B-47D5-A239-1DE111D20A9BQ36430739-3C0FC130-6D1C-4170-950C-D9DB8D65DE67Q36469889-14645E89-93D8-4C58-B10A-93ADFAA0C25EQ36799466-3655033D-97FB-4F2D-B3AB-B5D636D5F230Q37487211-A78E01A3-C5BE-4684-9932-093DCAAA8388Q37577370-9F1C10DD-F385-45D2-87A5-0CE7050E31CAQ37836264-650E1BEE-8FCB-4A7A-99C9-AEE96B04A532Q37864722-4BBFFFBD-8AB6-4197-ACF0-BC834173DCE7Q37972697-1D5C503A-3D20-4BD3-8EE6-9CF2E4E2659AQ38058243-70AA06A4-9134-41DC-98FF-29202D3A2DA4Q38808811-962F6698-62C6-44CC-932C-4377E33461C5Q38923075-E609B1A5-7F40-4250-978C-34B45E9771CCQ39673894-BEE23E5D-78E3-4052-B7F2-DD5F8789568AQ39687745-E0D4F45B-A6EA-41EF-9887-D5B97CD8B4DAQ40016930-29C2B2E3-E685-4A9D-87A6-502C8139F562Q42068278-AF70879D-4DFE-45DC-A6BA-22CA2FC19BBCQ42068385-9705C00D-2658-4A2D-B245-1D97035C59FEQ42546944-17F2A3F6-987D-42F9-86C5-5508BB6CBE7BQ42636324-A8773629-082D-4928-9C2B-922B8FEB16B3Q43805317-E9C81B3F-E14B-42C9-B6D1-8BE3C24090BCQ45359397-0C96D7B8-B37D-475C-BCE3-4D4A24149100Q45771110-2A761829-11F2-4A5E-8D2C-223D446725C7Q46961784-31A33BD2-7C6D-47DD-9483-06864C9C437C
P2860
Independent origin of multiple foci of prostatic intraepithelial neoplasia: comparison with matched foci of prostate carcinoma.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Independent origin of multiple ...... ed foci of prostate carcinoma.
@en
Independent origin of multiple ...... ed foci of prostate carcinoma.
@nl
type
label
Independent origin of multiple ...... ed foci of prostate carcinoma.
@en
Independent origin of multiple ...... ed foci of prostate carcinoma.
@nl
prefLabel
Independent origin of multiple ...... ed foci of prostate carcinoma.
@en
Independent origin of multiple ...... ed foci of prostate carcinoma.
@nl
P2093
P2860
P1433
P1476
Independent origin of multiple ...... ed foci of prostate carcinoma.
@en
P2093
Bostwick DG
Jenkins RB
P2860
P304
P356
10.1002/(SICI)1097-0142(19981101)83:9<1995::AID-CNCR16>3.0.CO;2-2
P407
P577
1998-11-01T00:00:00Z